sodium chloride 6%
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Jena
Overview
sodium chloride 6% is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
sodium chloride 6% clinical trials
Explore related
Medical disclaimer. This page summarizes research about sodium chloride 6% for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.